Wang, Xin Shelley https://orcid.org/0000-0003-2348-8005
Cleeland, Charles S. https://orcid.org/0000-0002-1460-6527
Article History
Received: 22 April 2025
Revised: 18 August 2025
Accepted: 4 September 2025
First Online: 19 September 2025
Declarations
:
: Not applicable.
: Not applicable.
: The MD Anderson Symptom Inventory (MDASI), a patient-reported outcomes measure discussed in this commentary, and its derivative versions are copyrighted and licensed by The University of Texas MD Anderson Cancer Center and Charles S. Cleeland. Charles S. Cleeland and Xin Shelley Wang have a financial interest in the MDASI and its derivative versions. The authors have no other relevant financial or non-financial interests to disclose.Xin Shelley Wang serves on the editorial board of Holistic Integrative Oncology. This manuscript was handled by another editor and has undergone rigorous peer review. Xin Shelley Wang was not involved in the journal’s peer review of, or decisions related to, this manuscript.